2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines

José Luis Zamorano(Centro de Investigación en Red en Enfermedades Cardiovasculares), Stephan Windecker(University of Bern), Teresa López‐Fernández(Hospital Universitario La Paz), Adam Torbicki(European Hospital), Dania Mohty(Centre Hospitalier Universitaire de Limoges), Thomas Suter(University of California San Diego), António Vaz Carneiro, Piotr Ponikowski(Wroclaw Medical University), Donna Fitzsimons(Queen's University Belfast), Scipione Carerj, Patrizio Lancellotti(Centre Hospitalier Universitaire de Liège), Gregory Y.H. Lip(Medical University of Białystok), Daniel J. Lenihan(Saint Francis Medical Center), Paulus Kirchhof(Universität Hamburg), Daniel Muñoz(Association of Chartered Certified Accountants), Héctor Bueno(Centro de Investigación en Red en Enfermedades Cardiovasculares), Çetin Erol(University of Turku), O. Gaemperli, Victor Aboyans(The Princess Grace Hospital), Alexander R. Lyon(Royal Brompton Hospital), Riccardo Asteggiano(University of Insubria), Gonzalo Barón‐Esquivias(San Raffaele University of Rome), Maurizio Galderisi, Gilbert Habib(Hôpital de la Timone), Massimo Piepoli(University of Milan), Patrizio Lancellotti(University of Liège), Stephan Achenbach, Petros Nihoyannopoulos, Philippe Kolh, Veronica Dean, Stefan Agewall(University of Oslo), Helmut Baumgartner, Jeroen J. Bax, Juan Tamargo(Hospital General Universitario Gregorio Marañón), Marco Roffi, Lina Badimón(Universitat de Vic - Universitat Central de Catalunya)
European Journal of Heart Failure
August 27, 2016
Cited by 1,802


Related Papers